- Immune Activation and Deficit in Neurotransmitters Synthesis in Treatment Resistant Depression: About a Case of Hashimoto Encephalopathy
-
Ellul P, Gasnier M, Trebossen V, Gaillard R
- KMID: 2505695
- Clin Psychopharmacol Neurosci.
- 2020 Aug;18(3):463-466.
- doi: 10.9758/cpn.2020.18.3.463
We report a case of Hashimoto encephalopathy initially presented as a drug-resistant depression with predominant apathy and asthenia, successfully treated with cyclophosphamide. We suspected that the psychiatric symptoms were due... -
- CITED
-
- Close
- SHARE
-
- Close
- A New Look on an Old Issue: Comprehensive Review of Neurotransmitter Studies in Cerebrospinal Fluid of Patients with Schizophrenia and Antipsychotic Effect on Monoamine’s Metabolism
-
Gasnier M, Ellul P, Plaze M, Ahad PA
- KMID: 2519539
- Clin Psychopharmacol Neurosci.
- 2021 Aug;19(3):395-410.
- doi: 10.9758/cpn.2021.19.3.395
Neurotransmitters metabolism has a key role in the physiopathology of schizophrenia as demonstrated by studies measuring monoamine metabolites in patient’s cerebrospinal fluid (CSF) since the beginning of the antipsychotic use.... -
- CITED
-
- Close
- SHARE
-
- Close
- Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later
-
Gasnier M, Choucha W, Montani D, Noël N, Verstuyft C, Radiguer F, Monnet X, Becquemont L, Corruble E, Colle R, on behalf of the COMEBAC Study Group
- KMID: 2536488
- Clin Psychopharmacol Neurosci.
- 2022 Nov;20(4):762-767.
- doi: 10.9758/cpn.2022.20.4.762
Objective: Psychiatric symptoms and mental disorders are common after Coronavirus Disease-19 (COVID-19). Some drugs used to treat acute COVID-19 have psychiatric side effects. We assessed the psychiatric symptoms and mental... -
- CITED
-
- Close
- SHARE
-
- Close
